Gerontopsychiatrie
Publisher
Springer Vienna
Reference89 articles.
1. Alexopoulos GS, Canuso CM, Gharabawi GM, Bossie CA, Greenspan A, Turkoz I, Reynolds C, III (2008) Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression. Am J Geriatr Psychiatry 16: 21–30 2. Allen TB, McEvoy JP (2002) Galantamine for treatment-resistant schizophrenia. Am J Psychiatry 159: 1244–1245 3. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K (2006) Nondegenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332 (7539): 455–459 4. Atri A, Shaughnessy LW, Locascio JJ, Growdon JH (2008) Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord 22 (3): 209–21 5. Ballard CG, Thomas A, Fossey J, Lee L, Jacoby R, Lana MM, Bannister C, McShane R, Swann A, Juszczak E (2004) A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. J Clin Psychiatry 65: 114–119
|
|